Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
39
SRTS Quote, Financials, Valuation and Earnings
Last price:
$3.79
Seasonality move
:
1.71%
Day range:
$3.76 - $3.85
52-week range:
$3.03 - $9.08
Dividend yield:
0%
P/E ratio:
34.65x
P/S ratio:
1.74x
P/B ratio:
1.22x
Volume:
10.1K
Avg. volume:
72.7K
1-year change:
-44.26%
Market cap:
$62.3M
Revenue:
$41.8M
EPS (TTM):
-$0.18
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare, Inc.
|
$6.3M | -$0.11 | -36.14% | -25.98% | $7.33 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$715.6K | -$0.05 | 272.5% | -33.67% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
|
XTNT
Xtant Medical Holdings, Inc.
|
$32.7M | -- | -2.42% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare, Inc.
|
$3.79 | $7.33 | $62.3M | 34.65x | $0.00 | 0% | 1.74x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8150 | $12.3077 | $209.3M | -- | $0.00 | 0% | 190.87x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.25 | $2.20 | $30.9M | -- | $0.00 | 0% | 17.27x |
|
VTAK
Catheter Precision, Inc.
|
$1.78 | -- | $2.2M | 0.40x | $0.00 | 0% | 8.37x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.78 | $1.50 | $108.9M | 76.27x | $0.00 | 0% | 0.85x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SRTS
Sensus Healthcare, Inc.
|
1.03% | 1.791 | 1.03% | 4.98x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | -0.348 | 537.37% | 0.41x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare, Inc.
|
$2.7M | -$2.6M | -5.58% | -5.65% | -37.32% | $2.3M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
Sensus Healthcare, Inc. vs. Competitors
-
Which has Higher Returns SRTS or CATX?
Perspective Therapeutics, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -12425.36%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About SRTS or CATX?
Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 93.49%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 349.19%. Given that Perspective Therapeutics, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Sensus Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SRTSSensus Healthcare, Inc.2 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is SRTS or CATX More Risky?
Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock SRTS or CATX?
Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SRTS or CATX?
Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Sensus Healthcare, Inc.'s net income of -$943K is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.74x versus 190.87x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SRTSSensus Healthcare, Inc.1.74x 34.65x $6.9M -$943K CATXPerspective Therapeutics, Inc.190.87x -- $209K -$26M
-
Which has Higher Returns SRTS or PMI?
Picard Medical has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of --. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M PMIPicard Medical-- -- -- -
What do Analysts Say About SRTS or PMI?
Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 93.49%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Sensus Healthcare, Inc. has higher upside potential than Picard Medical, analysts believe Sensus Healthcare, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings SRTSSensus Healthcare, Inc.2 0 0 PMIPicard Medical0 0 0 -
Is SRTS or PMI More Risky?
Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SRTS or PMI?
Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SRTS or PMI?
Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than Picard Medical quarterly revenues of --. Sensus Healthcare, Inc.'s net income of -$943K is higher than Picard Medical's net income of --. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.74x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SRTSSensus Healthcare, Inc.1.74x 34.65x $6.9M -$943K PMIPicard Medical-- -- -- --
-
Which has Higher Returns SRTS or VNRX?
VolitionRX Ltd. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -862.39%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About SRTS or VNRX?
Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 93.49%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 773.02%. Given that VolitionRX Ltd. has higher upside potential than Sensus Healthcare, Inc., analysts believe VolitionRX Ltd. is more attractive than Sensus Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SRTSSensus Healthcare, Inc.2 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is SRTS or VNRX More Risky?
Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock SRTS or VNRX?
Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SRTS or VNRX?
Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Sensus Healthcare, Inc.'s net income of -$943K is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.74x versus 17.27x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SRTSSensus Healthcare, Inc.1.74x 34.65x $6.9M -$943K VNRXVolitionRX Ltd.17.27x -- $627.3K -$5.4M
-
Which has Higher Returns SRTS or VTAK?
Catheter Precision, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of -1037.17%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About SRTS or VTAK?
Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 93.49%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 2034.9%. Given that Catheter Precision, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Catheter Precision, Inc. is more attractive than Sensus Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SRTSSensus Healthcare, Inc.2 0 0 VTAKCatheter Precision, Inc.0 0 0 -
Is SRTS or VTAK More Risky?
Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.301, suggesting its less volatile than the S&P 500 by 230.084%.
-
Which is a Better Dividend Stock SRTS or VTAK?
Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SRTS or VTAK?
Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Sensus Healthcare, Inc.'s net income of -$943K is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.74x versus 8.37x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SRTSSensus Healthcare, Inc.1.74x 34.65x $6.9M -$943K VTAKCatheter Precision, Inc.8.37x 0.40x $226K -$2.3M
-
Which has Higher Returns SRTS or XTNT?
Xtant Medical Holdings, Inc. has a net margin of -13.7% compared to Sensus Healthcare, Inc.'s net margin of 3.93%. Sensus Healthcare, Inc.'s return on equity of -5.65% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About SRTS or XTNT?
Sensus Healthcare, Inc. has a consensus price target of $7.33, signalling upside risk potential of 93.49%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 92.8%. Given that Sensus Healthcare, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Sensus Healthcare, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SRTSSensus Healthcare, Inc.2 0 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is SRTS or XTNT More Risky?
Sensus Healthcare, Inc. has a beta of 1.236, which suggesting that the stock is 23.559% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock SRTS or XTNT?
Sensus Healthcare, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SRTS or XTNT?
Sensus Healthcare, Inc. quarterly revenues are $6.9M, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Sensus Healthcare, Inc.'s net income of -$943K is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Sensus Healthcare, Inc.'s price-to-earnings ratio is 34.65x while Xtant Medical Holdings, Inc.'s PE ratio is 76.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare, Inc. is 1.74x versus 0.85x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SRTSSensus Healthcare, Inc.1.74x 34.65x $6.9M -$943K XTNTXtant Medical Holdings, Inc.0.85x 76.27x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
